Exploring COVID-19 Vaccine Hesitancy Amongst Black Americans: Contributing Factors and Motivators.
COVID-19
United States
black Americans
vaccine hesitancy
Journal
American journal of health promotion : AJHP
ISSN: 2168-6602
Titre abrégé: Am J Health Promot
Pays: United States
ID NLM: 8701680
Informations de publication
Date de publication:
11 2022
11 2022
Historique:
pubmed:
5
5
2022
medline:
1
11
2022
entrez:
4
5
2022
Statut:
ppublish
Résumé
To determine reasons for hesitancy towards COVID-19 vaccination and motivators to increase COVID-19 vaccine uptake among Black Americans. Mixed-methods. Individual interviews in March-April 2021. Black adults (20-79 years) who attended a church in Boston, MA and identified as "vaccine hesitant" (n = 18). Individual in-depth Zoom interviews to elicit participant views on vaccines in general, specific reasons for COVID-19 vaccine hesitancy, and trusted sources of information. Participants were also asked about possible motivators that could increase COVID-19 vaccine uptake. Transcripts were de-identified and analyzed for major themes using an inductive approach. Analysis included 18 complete interviews. Lack of trust in the government, healthcare, or pharmaceutical companies (n = 18), rushed development (n = 14), fear of side effects (n = 12), history of medical mistreatment (n = 12), and a perception of low risk of disease (n = 9) were the top-cited reasons for COVID-19 vaccine hesitancy. Motivators likely to increase COVID-19 vaccine uptake included more data (n = 17), friends and family getting vaccinated (not celebrities) (n = 11), and increased opportunities that come along with being vaccinated (n = 8). There were many reasons for COVID-19 vaccine hesitancy, as reported by participants who were all Black Americans in the Boston area. The public health challenge of increasing vaccine uptake in the Black community is nuanced and intervention efforts may be more successful if delivered by trusted members of the community and tailored to the needs of individuals.
Identifiants
pubmed: 35506153
doi: 10.1177/08901171221099270
pmc: PMC9618913
doi:
Substances chimiques
COVID-19 Vaccines
0
Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Pagination
1304-1315Références
Ann Epidemiol. 2020 Jul;47:37-44
pubmed: 32419766
PRiMER. 2017 Aug 31;1:15
pubmed: 32944701
Soc Sci Med. 2019 Jan;221:87-94
pubmed: 30576982
Expert Rev Vaccines. 2020 Oct;19(10):919-936
pubmed: 32940090
J Community Health. 2021 Apr;46(2):270-277
pubmed: 33389421
Brain Behav Immun Health. 2020 Dec;9:100159
pubmed: 33052327
J Acquir Immune Defic Syndr. 2021 Feb 1;86(2):200-207
pubmed: 33196555
Soc Sci Med. 2017 Nov;193:70-79
pubmed: 29028558
Vaccine. 2019 Feb 21;37(9):1168-1173
pubmed: 30709722
Vaccine. 2021 Jun 2;39(24):3250-3258
pubmed: 33966909
J Microbiol Biotechnol. 2020 Mar 28;30(3):313-324
pubmed: 32238757
Hum Vaccin Immunother. 2018 Jul 3;14(7):1599-1609
pubmed: 29617183
Soc Sci Med. 2021 Mar;272:113638
pubmed: 33414032
Immunity. 2020 May 19;52(5):737-741
pubmed: 32433946
J Gen Intern Med. 2021 Nov;36(11):3629-3631
pubmed: 34021446
Fam Med. 2020 Oct;52(9):626-630
pubmed: 33030717
Am J Public Health. 1997 Nov;87(11):1773-8
pubmed: 9366634
BMC Public Health. 2021 Apr 28;21(1):818
pubmed: 33910558
PLoS Curr. 2016 Dec 29;8:
pubmed: 28239512
Vaccine. 2018 Oct 22;36(44):6556-6558
pubmed: 28830694